Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics.
This report contains market size and forecasts of Nuclear Medicine Radioisotopes in global, including the following market information:
Global Nuclear Medicine Radioisotopes Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nuclear Medicine Radioisotopes Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Nuclear Medicine Radioisotopes companies in 2021 (%)
The global Nuclear Medicine Radioisotopes market was valued at 3558 million in 2021 and is projected to reach US$ 4423.1 million by 2028, at a CAGR of 3.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Thallium-201 (Tl-201) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nuclear Medicine Radioisotopes include Agfa-Gevaert Group, Braco, Cardiarc, Cardinal Health, CMR Naviscan (Gamma Medica Inc.), Curium, Digirad, GE Healthcare and Nordion (Canada), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nuclear Medicine Radioisotopes manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nuclear Medicine Radioisotopes Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nuclear Medicine Radioisotopes Market Segment Percentages, by Type, 2021 (%)
Thallium-201 (Tl-201)
Iodine (I-123)
Fluorine-18
Rubidium-82 (Rb-82)
Other
Global Nuclear Medicine Radioisotopes Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nuclear Medicine Radioisotopes Market Segment Percentages, by Application, 2021 (%)
Tumor
Heart Disease
Lymphoma
Thyroid Gland
Other
Global Nuclear Medicine Radioisotopes Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nuclear Medicine Radioisotopes Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nuclear Medicine Radioisotopes revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nuclear Medicine Radioisotopes revenues share in global market, 2021 (%)
Key companies Nuclear Medicine Radioisotopes sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Nuclear Medicine Radioisotopes sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Agfa-Gevaert Group
Braco
Cardiarc
Cardinal Health
CMR Naviscan (Gamma Medica Inc.)
Curium
Digirad
GE Healthcare
Nordion (Canada)
NTP Radioisotopes SOC
Positron
Segami
Siemens Healthcare